ARMISTICE CAPITAL, LLC

Holdings History for SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN)

Symbol: SUPN on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock, $0.001 par value per share
Latest Disclosed Ownership: 4.84M shares
Security Ownership: 8.76%

Shares, Excluding Options vs Price

Value, Excluding Options

Armistice Capital, LLC ownership in SUPERNUS PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (SUPN)

2025-02-14 - Armistice Capital, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4.84M shares of SUPERNUS PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (SUPN). This represents 8.76% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Armistice Capital, LLC	8.76%		$155M	4.84M			$32.02	13G/A	12/31/2024	14 Feb 2025 17:20:51

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	4.07%	-0.22%	$175M	4.84M	-260,000	-5.1%	$36.16	Q4 2024
9/30/2024	4.16%	-0.14%	$159M	5.1M	-176,000	-3.34%	$31.18	Q3 2024
6/30/2024	3.69%	+1.22%	$141M	5.27M	+1,700,000	+47.6%	$26.75	Q2 2024
3/31/2024	3.24%	-0.5%	$122M	3.57M	-1,078,000	-23.2%	$34.11	Q1 2024
12/31/2023	1.84%	-0.2%	$135M	4.65M	-442,000	-8.68%	$28.94	Q4 2023
9/30/2023	2.15%	+0.02%	$140M	5.09M	+56,000	+1.11%	$27.57	Q3 2023
6/30/2023	2.19%	+0.3%	$151M	5.04M	+686,000	+15.8%	$30.06	Q2 2023
3/31/2023	2.27%	0%	$158M	4.35M	-6,000	-0.14%	$36.23	Q1 2023
12/31/2022	2.71%	-0.15%	$155M	4.36M	-237,004	-5.16%	$35.67	Q4 2022
9/30/2022	2.7%	-0.07%	$155M	4.59M	-118,996	-2.53%	$33.85	Q3 2022
6/30/2022	2.38%	+0.81%	$136M	4.71M	+1,612,000	+52%	$28.92	Q2 2022
3/31/2022	1.94%	-0.65%	$100M	3.1M	-1,036,000	-25%	$32.32	Q1 2022
12/31/2021	1.97%	+0.11%	$121M	4.14M	+236,000	+6.05%	$29.16	Q4 2021
9/30/2021	2.57%	+0.41%	$104M	3.9M	+576,000	+17.3%	$26.67	Q3 2021
6/30/2021	2.69%	-0.06%	$102M	3.32M	-88,000	-2.58%	$30.79	Q2 2021
3/31/2021	2.86%	+0.34%	$89.3M	3.41M	+292,000	+9.36%	$26.18	Q1 2021
12/31/2020	3.51%	-0.09%	$78.5M	3.12M	-80,000	-2.5%	$25.16	Q4 2020
9/30/2020	2.42%	+0.75%	$66.7M	3.2M	+992,000	+44.9%	$20.84	Q3 2020
6/30/2020	2.3%	-0.83%	$52.4M	2.21M	-792,000	-26.4%	$23.75	Q2 2020
3/31/2020	3.34%	+1.43%	$54M	3M	+1,288,000	+75.2%	$17.99	Q1 2020
12/31/2019	2.34%	+2.34%	$40.6M	1.71M	+1,712,000	NEW	$23.72	Q4 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.